Headache

1. Gantenbein AR, Bonvin C, Kamm CP, Schankin CJ, et al. Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results. J Neurol. 2024 Jun 13. doi:10.1007/s00415-024-12470-6.
    
2. Jesse CM, (...) Schankin CJ, et al. Improvement of health-related quality of life after closure of spinal CSF leaks in patients with spontaneous intracranial hypotension. J Neurosurg Spine. 2024 Jun 14:1-7. doi:10.3171/2024.4.SPINE231232.
    
3. Merki-Feld G, Dietrich H, Imesch P, Gantenbein AR, Sandor P, Schankin CJ. Investigating migraine phenotype and dynamics in women with endometriosis: an observational pilot study. Acta Neurol Belg. 2024 Jun 15. doi:10.1007/s13760-024-02484-2.

Neuroimmunology

1. Friedli C, Krajnc N, Hammer HN, Marti S, Zrzavy T, Evangelopoulos ME, Kapsali I, Rommer P, Berger T, Chan A, Bsteh G, Hoepner R. Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study. J Cent Nerv Syst Dis. 2024 May 5:16:11795735241249644. doi:10.1177/11795735241249644.
    
2. Gruchot J, Reiche L, Chan A, Hoepner R, Küry P. Human endogenous retrovirus type-W and multiple sclerosis-related smoldering neuroinflammation. Neural Regeneration Research 20(3):p 813-814, March 2025. doi:10.4103/NRR.NRR-D-24-00121.

Neuromuscular Center

1. Steiner L, Tscherter A, Henzi B, Branca M, Carda S, Enzmann C, Fluss J, Jacquier D, Neuwirth C, Ripellino P, Scheidegger O, Schlaeger R, Schreiner B, Stettner GM, Klein A; Swiss-Reg-NMD Group. Chronic Pain in Patients with Spinal Muscular Atrophy in Switzerland: A Query to the Spinal Muscular Atrophy Registry. J Clin Med. 2024 May 9;13(10):2798. doi:10.3390/jcm13102798.

Neuropsychology

1. Bland AR, Barraclough M, Trender WR, Mehta MA, Hellyer PJ, Hampshire A, Penner IK, Elliott R, Harenwall S. Profiles of objective and subjective cognitive function in Post-COVID Syndrome, COVID-19 recovered, and COVID-19 naïve individuals. Sci Rep. 2024 Jun 11;14(1):13368. doi:10.1038/s41598-024-62050-x.
    
2. Studer M, Mischler L, Romano F, Lidzba K, Bigi S. Different trajectories of post-concussive symptom subscales after pediatric mild traumatic brain injury: Data from a prospective longitudinal study. Eur J Paediatr Neurol. 2024 May 8:51:9-16. doi:10.1016/j.ejpn.2024.05.003.
    
3. Wiemann M #, Blendow SL #, Zimowski N, Enax-Krumova E, Fleischmann R, Penner IK, Grothe M, Strauss S. The role of fatigue in patients with complex regional pain syndrome. J Neurol. 2024 Jun 8. doi:10.1007/s00415-024-12473-3. 

Neurorehabilitation

1. Gallucci L, Sperber C, Guggisberg AG, Kaller CP, Heldner MR, Monsch AU, Hakim A, Silimon N, Fischer U, Arnold M, Umarova RM. Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment. Int J Stroke. 2024 Mar 21:17474930241238637. doi:10.1177/17474930241238637.
    
2. Smaczny S, Bauder D, Sperber C, Karnath HO, de Haan B. Reducing alertness does not affect line bisection bias in neurotypical participants. Exp Brain Res. 2024 Jan;242(1):195-204. doi:10.1007/s00221-023-06738-y.
    
3. Studer M, Guggisberg AG, Gyger N, Gutbrod K, Henke K, Heinemann D. Accelerated long-term forgetting in patients with acquired brain injury. Brain Inj. 2024 Apr 15;38(5):377-389. doi:10.1080/02699052.2024.2311349.

Psychosomatic Medicine

1. Schneider A, Weber S, Wyss A, Loukas S, Aybek S. BOLD signal variability as potential new biomarker of functional neurological disorders. Neuroimage Clin. 2024 May 31:43:103625. doi:10.1016/j.nicl.2024.103625.

Sleep

1. Bassetti CLA, Sohm F, Adamantidis A, Schindler K, Barazzoni F, Manconi M. The International Master of Advanced Studies (MAS) in Sleep Medicine of the Universities of Bern and Svizzera Italiana. Clinical and Translational Neuroscience. 2024; 8(2):19. doi:10.3390/ctn8020019. 

Stroke

1. Berberich A #, Herweh C #, (...) Fischer U, et al.  Endovascular therapy of isolated posterior cerebral artery occlusion stroke with and without general anesthesia. J Neurointerv Surg. 2024 Jun 5:jnis-2024-021633. doi:10.1136/jnis-2024-021633. 
    
2. Berger C, Hammer H, Costa M, Lowiec P, Yagensky A, Scutelnic A, Antonenko K, Biletska O, Karaszewski B, Sarikaya H, Zdrojewski T, Klymiuk A, Bassetti CLA, Yashchuk N, Chwojnicki K, Arnold M, Saner H, Heldner MR. Baseline characteristics, reperfusion treatment secondary prevention and outcome after acute ischemic stroke in three different socioeconomic environments in Europe. Eur Stroke J. 2024 May 14:23969873241245518. doi:10.1177/23969873241245518.
    
3. Bücke P, Jung S, Kaesmacher J, Goeldlin MB, Horvath T, Prange U, Beyeler M, Fischer U, Arnold M, Seiffge DJ, Meinel TR. Intravenous thrombolysis in patients with recent intake of direct oral anticoagulants: A target trial analysis after the liberalization of institutional guidelines. Eur Stroke J. 2024 May 13:23969873241252751. doi:10.1177/23969873241252751.  
    
4. Connolly SJ, (...) Seiffge DJ, et al. Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage. N Engl J Med. 2024 May 16;390(19):1745-1755. doi:10.1056/NEJMoa2313040. 
    
5. Galea R, (...) Seiffge DJ, Roten L, Siontis GCM, Heg D, Windecker S, Räber L. Pericardial Effusion After Left Atrial Appendage Closure: Timing, Predictors, and Clinical Impact. JACC Cardiovasc Interv. 2024 Jun 10;17(11):1295-1307. doi:10.1016/j.jcin.2024.01.310.
    
6. Goeldlin MB, Hakim A, Branca M, Abend S, Kneihsl M, Valenzuela Pinilla W, (...) Nedeltchev K, (...) Horvath T, (...) Fischer U; ELAN Investigators. Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. JAMA Neurol. 2024 May 28:e241450. doi:10.1001/jamaneurol.2024.1450.Palaiodimou L, (...) 
    
7. Kaufmann JE, (...) Kägi G, Nedeltchev K, (...) Arnold M, et al. Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis. JAMA Neurol. 2024 Jun 1;81(6):630-637. doi:10.1001/jamaneurol.2024.1141.
    
8. Kelly P, (...) Fischer U, et al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial. Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi:10.1016/S0140-6736(24)00968-1.
    
9. Lee S, (...) Arnold M, et al. Thrombectomy in young adults with embolic stroke of undetermined source: Analysis of the Young ESUS study. J Stroke Cerebrovasc Dis. 2024 Jun 10;33(8):107811. doi:10.1016/j.jstrokecerebrovasdis.2024.107811.
    
10. Mujanovic A, (...) Seiffge DJ, (...) Fischer U, Nguyen TN, Kaesmacher J. Safety and clinical outcomes of endovascular therapy versus medical management in late presentation of large ischemic stroke. Eur Stroke J. 2024 May 17:23969873241249406. doi:10.1177/23969873241249406.
     
11. Seiffge DJ, Tsivgoulis G. Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis. Eur Stroke J. 2024 May 14:23969873241251931. doi:10.1177/23969873241251931.
     
12. Seiffge DJ, Anderson CS. Treatment for intracerebral hemorrhage: Dawn of a new era. Int J Stroke. 2024 Jun;19(5):482-489. doi:10.1177/17474930241250259.
     
13. Seiffge DJ. Good Treatment of Hyperacute Intracerebral Hemorrhage Is as Easy as ABC. Neurology. 2024 Jul 23;103(2):e209614. doi:10.1212/WNL.0000000000209614.
     
14. Steinauer F, Bücke P, (...) Clenin L, Goeldlin M, Lippert J, Volbers B, Meinel TR, Seiffge D, Mujanovic A, Kaesmacher J, Fischer U, Arnold M, Pabst T, Berger MD, Jung S, Beyeler M. Prevalence of right-to-left shunt in stroke patients with cancer. Int J Stroke. 2024 Jun 13:17474930241260589. doi:10.1177/17474930241260589.
     
15. Zietz A, (...) Arnold M, Schaedelin S, Müri RM, et al. Enhancement of STroke REhabilitation with Levodopa (ESTREL): Rationale and design of a randomized placebo-controlled, double blind superiority trial. Eur Stroke J. 2024 Jun 9:23969873241255867. doi:10.1177/23969873241255867.

SWEZ

1. Kasper BS, (...) Caciagli L, et al. ILAE neuroimaging task force highlight: Subcortical laminar heterotopia. Epileptic Disord. 2024 Apr;26(2):225-232. doi:10.1002/epd2.20206.
    
2. Xie K, (...) Caciagli L, et al. Atypical connectome topography and signal flow in temporal lobe epilepsy. Prog Neurobiol. 2024 May:236:102604. doi:10.1016/j.pneurobio.2024.102604.

ZEN

1. van Maren E, Alnes SL, Ramos da Cruz J, Sobolewski A, Friedrichs-Maeder C, Wohler K, Barlatey SL, Feruglio S, Fuchs M, Vlachos I, Zimmermann J, Bertolote T, Z'Graggen WJ, Tzovara A, Donoghue J, Kouvas G, Schindler K, Pollo C, Baud MO. Feasibility, Safety, and Performance of Full-Head Subscalp EEG Using Minimally Invasive Electrode Implantation. Neurology. 2024 Jun 25;102(12):e209428. doi:10.1212/WNL.0000000000209428.

ZfPB

1. Höglinger G, German Parkinson’s Guidelines Committee, Trenkwalder C. Diagnosis and treatment of Parkinson´s disease (guideline of the German Society for Neurology). Neurol Res Pract. 2024 Jun 6;6(1):30. doi:10.1186/s42466-024-00325-4.

General Neurology

1. Karafyllis I, Nuoffer JM, Michelis JP, Chilver-Stainer L. Untreated Classic Galactosemia: A Rare Cause of Adult-Onset Progressive Cerebellar Ataxia - A Case Report. Case Rep Neurol. 2024 Feb 7;16(1):55-62. doi:10.1159/000536679. 

Headache

1. Klein A, Aeschlimann SA, Zubler F, Scutelnic A, Riederer F, Ertl M, Schankin CJ. Alterations of the alpha rhythm in visual snow syndrome: a case-control study. J Headache Pain. 2024 Apr 8;25(1):53. doi:10.1186/s10194-024-01754-x.
    
2. Riederer F, Beiersdorf J, Lang C, Pirker-Kees A, Klein A, Scutelnic A, Platho-Elwischger K, Baumgartner C, Dreier JP, Schankin C. Signatures of migraine aura in high-density-EEG. Clin Neurophysiol. 2024 Apr:160:113-120. doi:10.1016/j.clinph.2024.01.008.
    
3. Scutelnic A, Sutter NL, Beyeler M, Meinel TR, Riederer F, Fischer U, Arnold M, Mattle HP, Jung S, Schankin CJ. Characteristics of acute ischemic stroke and unusual aura in patients with migraine with aura. Headache. 2024 Mar;64(3):253-258. doi:10.1111/head.14682.
    
4. Wegener S, Gantenbein AR, Grossmann HF, Schankin CJ, Kleinschmidt A. Bessere Hirngesundheit bessere Lebensqualität. Schweiz Ärzteztg. 2024;105(15). doi:10.4414/saez.2024.1412108784. 
    
5. You H, Schankin C. Die Therapie der Migräne. HAUSARZT PRAXIS 2024; Vol. 19, Nr. 1 Link

Neuroimmunology

1. Diem L, Ovchinnikov A, Friedli C, Hammer H, Kamber N, Chan A, Salmen A, Findling O, Hoepner R. Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: real-world experience of two Swiss Multiple Sclerosis centers. Mult Scler Relat Disord. 2024 Mar 30:86:105570. doi:10.1016/j.msard.2024.105570.
    
2. Lux J, (...) Hoepner R, et al. Klebsiella pneumoniae peptide hijacks a Streptococcus pneumoniae permease to subvert pneumococcal growth and colonization. Commun Biol. 2024 Apr 8;7(1):425. doi:10.1038/s42003-024-06113-9.
    
3. Rebsamen M, Capiglioni M, Hoepner R, Salmen A, Wiest R, Radojewski P, Rummel C. Growing importance of brain morphometry analysis in the clinical routine: The hidden impact of MR sequence parameters. J Neuroradiol. 2024 Feb;51(1):5-9. doi:10.1016/j.neurad.2023.04.003.
    
4. Thränhardt P, Veselaj A, Friedli C, Wagner F, Marti S, Diem L, Hammer H, Radojewski P, Wiest R, Chan A, Hoepner R, Salmen A. Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events. Ther Adv Neurol Disord. 2024 Mar 26:17:17562864241237853. doi:10.1177/17562864241237853.

Neurorehabilitation

1. Gallucci L, Sperber C, Guggisberg AG, Kaller CP, Heldner MR, Monsch AU, Hakim A, Silimon N, Fischer U, Arnold M, Umarova RM. Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment. Int J Stroke. 2024 Mar 21:17474930241238637. doi:10.1177/17474930241238637.
    
2. Smaczny S, Bauder D, Sperber C, Karnath HO, de Haan B. Reducing alertness does not affect line bisection bias in neurotypical participants. Exp Brain Res. 2024 Jan;242(1):195-204. doi:10.1007/s00221-023-06738-y.
    
3. Studer M, Guggisberg AG, Gyger N, Gutbrod K, Henke K, Heinemann D. Accelerated long-term forgetting in patients with acquired brain injury. Brain Inj. 2024 Apr 15;38(5):377-389. doi:10.1080/02699052.2024.2311349.

Psychosomatic Medicine

1. Weber S, Bühler J, Loukas S, Bolton TAW, Vanini G, Bruckmaier R, Aybek S. Transient resting-state salience-limbic co-activation patterns in functional neurological disorders. Neuroimage Clin. 2024:41:103583. doi:10.1016/j.nicl.2024.103583.
    
2. Weber S, Bühler J, Messmer F, Bruckmaier R, Aybek S. Cortisol in functional neurological disorders: State, trait and prognostic biomarkers. J Psychosom Res. 2024 Apr:179:111615. doi:10.1016/j.jpsychores.2024.111615. 

Stroke

1. Coutinho JM, (...) Heldner MR, (...) Arnold M, Ferro JM. Reducing the global burden of cerebral venous thrombosis: an international research agenda. Int J Stroke. 2024 Apr 9:17474930241242266. doi:10.1177/17474930241242266.
    
2. Kaufmann J, Buecke P, Meinel T, Beyeler M, Scutelnic A, Kaesmacher J, Mujanović A, Dobrocky T, Arsany H, Peters N, Z'Graggen W, Jung S, Seiffge D. Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) - A systematic review. Eur J Neurol. 2024 May;31(5):e16246. doi:10.1111/ene.16246.
    
3. Khanafer A, Henkes H, Bücke P, et al. Triple platelet inhibition in intracranial thrombectomy with additional acute cervical stent angioplasty due to tandem lesion: a retrospective single-center analysis. BMC Neurol. 2024 Mar 18;24(1):99. doi:10.1186/s12883-024-03597-0. 
    
4. Peycheva M†, Padlina G†, Genceviciute K, Krasteva MP, Boronylo A, Goeldlin MB, Müller M, Wenz ES, Müller MD, Hammer H, Bücke P, Bigi S, Goeggel Simonetti B, Hoffmann A, Umarova RM, Pilgram-Pastor S, Gralla J, Mordasini P, Antonenko K†, Heldner MR†. Baseline characteristics and outcome of stroke patients after endovascular therapy according to previous symptomatic vascular disease and sex. Front. Neurol. 15:1293905. doi:10.3389/fneur.2024.1293905.
    
5. Scutelnic A, (...) Antonenko K, (...) Arnold M, Heldner MR. Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19. Eur Stroke J. 2024 Apr 4:23969873241241885. doi:10.1177/23969873241241885.
    
6. Seiffge DJ, (...) Fischer U, et al. Secondary stroke prevention in people with atrial fibrillation: treatments and trials. Lancet Neurol. 2024 Apr;23(4):404-417. doi:10.1016/S1474-4422(24)00037-1.
    
7. Siepen BM, (...) Goeldlin MB, Müller M, Branca M, Rauch J, Meinel T, Kaesmacher J, Z'Graggen W, Arnold M, Fischer U, (...) Seiffge D. Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors - Individual patient data analysis of ANNEXA-4 and TICH-NOAC. Int J Stroke. 2024 Mar 8:17474930241230209. doi:10.1177/17474930241230209.
    
8. Slavova N #, Muenger R #, et al. Inflammatory Type Focal Cerebral Arteriopathy of the Posterior Circulation in Children: A Comparative Cohort Study. Stroke. 2024 Apr;55(4):1006-1014. doi:10.1161/STROKEAHA.123.043562.
    
9. Steinsiepe VK, Sarikaya H, Mordasini PR, Wegener S, Inauen C, Baumgartner P, Jung S, Antonenko K, Fischer U, Gralla J, Umarova RM, Goeggel Simonetti B, van Laarhoven CJHCM, de Borst GJ, Chabriat H, Heldner MR†, Arnold M†. Comparison of Aneurysmal and Non-Aneurysmal Spontaneous Cervical Artery Dissections in a Large Multicenter Cohort.Clinical and Translational Neuroscience. 2024; 8(2):18. doi:10.3390/ctn8020018.

SWEZ/ZEN: e-lab

1. Friedrichs-Maeder C,Proix T, Tcheng TK, Skarpaas T, Rao VR, Baud MO. Seizure Cycles under Pharmacotherapy. Ann Neurol. 2024 Apr;95(4):743-753. doi:10.1002/ana.26878.

SWEZ

1. Trimmel K, Vos SB, Binding L, Caciagli L, Xiao F, van Graan LA, Koepp MJ, Thompson PJ, Duncan JS. Naming fMRI-guided white matter language tract volumes influence naming decline after temporal lobe resection. J Neurol. 2024 Apr 7. doi:10.1007/s00415-024-12315-2.
    
2. Yilmaz G, Seiler A, Chételat O, Schindler KA. Ultra-Long-Term-EEG Monitoring (ULTEEM) Systems: Towards User-Friendly Out-of-Hospital Recordings of Electrical Brain Signals in Epilepsy. Sensors (Basel). 2024 Mar 14;24(6):1867. doi:10.3390/s24061867.

ZfPB

1. Bange M, Gonzalez-Escamilla G, Herz DM, Tinkhauser G, et al. Subthalamic stimulation modulates context-dependent effects of beta bursts during fine motor control. Nat Commun. 2024 Apr 12;15(1):3166. doi:10.1038/s41467-024-47555-3.
    
2. Menéndez-Granda M, Schmidt N, Orth M, et al. The effect of loss incentives on prospective memory in healthy older adults: study protocol of a randomized controlled trial using ultra-high field fMRI. BMC Psychiatry. 2023 Oct 6;23(1):722. doi:10.1186/s12888-023-05229-2.
    
3. Ojo OO, (...) Nigeria Parkinson's Disease Research Network and the Global Parkinson's Genetics Program (GP2) [Krack P]. GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians. Mov Disord. 2024 Apr;39(4):728-733. doi:10.1002/mds.29753.

Neuroimmunology

1. Wiendl H, Abicht A, Chan A, et al. Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord. 2023 Dec 26:16:17562864231213240. doi:10.1177/17562864231213240.

Neuromuscular Center

1. Abbuehl LS, Branca M, Ungureanu A, Federspiel A, Leib SL, Bassetti CLA, Hakim A #, Dietmann A #. Magnetic resonance imaging in acute meningoencephalitis of viral and unknown origin: frequent findings and prognostic potential. Front Neurol. 2024 Jan 17:15:1359437. doi:10.3389/fneur.2024.1359437.

Neurorehabilitation

1. Nelles G. et al. [Beteiligte Fachgesellschaft, SGNR/ SNG: Guggisberg A], Rehabilitation sensomotorischer Störungen, S2k-Leitlinie, 2023, in: Deutsche Gesellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. Link
    
2. Hakim A, Gallucci L, Sperber C, Rezny-Kasprzak B, Jäger E, Meinel T, Seiffge D, Goeldlin M, Westphalen F, Fischer U, Wiest R, Arnold M, Umarova R. The analysis of association between single features of small vessel disease and stroke outcome shows the independent impact of the number of microbleeds and presence of lacunes. Sci Rep. 2024 Feb 10;14(1):3402. doi:10.1038/s41598-024-53500-7.
    
3. Sperber C, Hakim A, Gallucci L, Arnold M, Umarova RM. Cerebral small vessel disease and stroke: Linked by stroke aetiology, but not stroke lesion location or size. J Stroke Cerebrovasc Dis. 2024 Jan 18;33(4):107589.doi:10.1016/j.jstrokecerebrovasdis.2024.107589.
    
4. Umarova RM, Gallucci L, Hakim A, Wiest R, Fischer U, Arnold M. Adaptation of the Concept of Brain Reserve for the Prediction of Stroke Outcome: Proxies, Neural Mechanisms, and Significance for Research. Brain Sci. 2024 Jan 12;14(1):77. doi:10.3390/brainsci14010077.

Psychosomatic/Neurorehabilitation

1. Blondiaux E, Diamantaras A, Schumacher R, Blanke O, Müri R, Heydrich L. The neural correlates of topographical disorientation-a lesion analysis study. Ann Clin Transl Neurol. 2024 Feb;11(2):520-524. doi:10.1002/acn3.51967.

Stroke

1. Antonenko K, Mosconi MG. Progress in Diagnosis and Treatment: The Last 50 Years of Stroke Prevention. in: Bogousslavsky J, et al. History of Stroke. Dec. 2023. Basel: MDPI. pp. 91-101. doi:10.3390/books978-3-0365-2313-2.  
    
2. Bettschen E, Siepen BM, Goeldlin MB, Mueller M, Buecke P, Prange U, Meinel TR, Drop BRH, Bervini D, Dobrocky T, Kaesmacher J, Exadaktylos AK, Sauter TC, Volbers B, Arnold M, Jung S, Fischer U, Z'Graggen W, Seiffge D. Time for "code ICH"? - Workflow metrics of hyperacute treatments and outcome in patients with intracerebral haemorrhage. Cerebrovasc Dis. 2024 Jan 10. doi:10.1159/000536099.
    
3. Buecke P, et al. The History of Endovascular Stroke Treatment: From Local Intraarterial Fibrinolysis to Stent Retriever Thrombectomy. Rofo. 2023 Dec 8. doi:10.1055/a-2206-6223.
    
4. Goeldlin MB, Mueller M, Siepen BM, (...) Meinel TR, Clénin L, (...) Arnold M, (...) Fischer U, Werring DJ, Seiffge DJ; for Swiss Stroke Registry Investigators and SIGNAL Investigators 1. CADMUS: A Novel MRI-Based Classification of Spontaneous Intracerebral Hemorrhage Associated With Cerebral Small Vessel Disease. Neurology. 2024 Jan 9;102(1):e207977. doi:10.1212/WNL.0000000000207977.
    
5. Hajiyev K, Henkes H, Khanafer A, Bücke P, et al. Drug-Coated Balloons for Treatment of Internal Carotid Artery Restenosis After Stenting: A Single-Center Mid-Term Outcome Study. Cardiovasc Intervent Radiol. 2024 Feb 7. doi:10.1007/s00270-024-03663-7.
    
6. Ip B, (...) Seiffge D, Leung T. Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants. JAMA Netw Open. 2024 Feb 5;7(2):e2354916. doi:10.1001/jamanetworkopen.2023.54916.
    
7. Kaesmacher J, (...) Meinel TR, Guo C, Seiffge D, (...) Fischer U, Roos Y, Gralla J; IRIS Collaborators. Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis. JAMA. 2024 Feb 7:e240589. doi:10.1001/jama.2024.0589.
    
8. Meinel TR, Wardlaw JM, Kent DM. Is Incidentally Discovered Covert Cerebrovascular Disease Ignorable? JAMA Neurol. 2024 Feb 5. doi:10.1001/jamaneurol.2023.5456.
    
9. Mujanovic A, (...) Meinel TR, Seiffge DJ, Jung S, Arnold M, Nguyen TN, Fischer U, et al.  Value of Immediate Flat Panel Perfusion Imaging after Endovascular Therapy (AFTERMATH): A Proof of Concept Study. AJNR Am J Neuroradiol. 2024 Feb 7;45(2):163-170. doi:10.3174/ajnr.A8103.
    
10. Parry-Jones AR, (...) Seiffge D, et al. Acute care bundles should be used for patients with intracerebral haemorrhage: An expert consensus statement. Eur Stroke J. 2023 Dec 27:23969873231220235. doi:10.1177/23969873231220235.
     
11. Peycheva M, Zdravkova T, Zlatareva D, Viteva E, Harizanova Z, Meinel TR, Heldner MR. Transient perivascular inflammation of the carotid artery-A transient but potentially recurrent disease. Clin Case Rep. 2024 Jan 18;12(1):e8322. doi:10.1002/ccr3.8322.
     
12. Purrucker JC, Meinel TR, Wilson D, Xian Y, Wu TY, Seiffge DJ. Thrombolysis for ischaemic stroke despite direct oral anticoagulation. Stroke Vasc Neurol. 2024 Jan 31:svn-2023-002727. doi:10.1136/svn-2023-002727.
     
13. Siepen BM, Forfang E, Branca M, Drop B, Mueller M, Goeldlin MB, (...) Kägi G, (...) Volbers B, Meinel TR, Arnold M, Engelter ST, Bonati LH, Fischer U, Rønning OM, Seiffge DJ. Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries. Stroke Vasc Neurol. 2024 Feb 8:svn-2023-002813. doi:10.1136/svn-2023-002813.
     
14. Yaghi S, (...) Heldner MR, Antonenko K, Seiffge DJ, Arnold M, et al. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study. Stroke. 2024 Feb 9. doi:10.1161/STROKEAHA.123.045731.

Sleep/Stroke

1. Yang X #, Lippert J #, Dekkers M, Baillieul S, Duss SB, Reichlin T, Brill AK, Bernasconi C, Schmidt MH, Bassetti CLA. Impact of Comorbid Sleep-Disordered Breathing and Atrial Fibrillation on the Long-Term Outcome After Ischemic Stroke. Stroke. 2024 Jan 26. doi:10.1161/STROKEAHA.123.042856.

ZEN

1. Alnes SL, Bächlin LZM, Schindler K, Tzovara A. Neural complexity and the spectral slope characterise auditory processing in wakefulness and sleep. Eur J Neurosci. 2023 Dec 15. doi:10.1111/ejn.16203.
    
2. Canet G, (...) Pernet V, Planel E. Temperature-induced Artifacts in Tau Phosphorylation: Implications for Reliable Alzheimer's Disease Research. Exp Neurobiol. 2023 Dec 31;32(6):423-440. doi:10.5607/en23025.
    
3. Joly S, Augusto G, Mdzomba B, Meli I, Vogel M, Chan A, Pernet V. Nogo-A neutralization in the central nervous system with a blood-brain barrier-penetrating antibody. J Control Release. 2023 Dec 29:366:52-64. doi:10.1016/j.jconrel.2023.12.041.
    
4. Tzovara A, Fedele T, Sarnthein J, Ledergerber D, Lin JJ, Knight RT. Predictable and unpredictable deviance detection in the human hippocampus and amygdala. Cereb Cortex. 2024 Jan 31;34(2):bhad532. doi:10.1093/cercor/bhad532.

ZfPB

1. Benis D, (...) Krack P, Péron J, Fleury V. Electroencephalographic Abnormalities in a Patient Suffering from Long-Term Neuropsychological Complications following SARS-CoV-2 Infection. Case Rep Neurol. 2023 Dec 5;16(1):6-17. doi:10.1159/000535241.
    
2. Cuartero MC, (...) Krack P, et al. Lessons from multitarget neurostimulation in isolated dystonia: Less is more? Brain Stimul. 2024 Jan-Feb;17(1):104-106. doi.org/10.1016/j.brs.2023.12.012
    
3. Debove I, Paschen S, Amstutz D, (...) Krack P, Deuschl G; and the Members of the ICBD in PD Management Consensus Group. Management of Impulse Control and Related Disorders in Parkinson’s Disease: An Expert Consensus. Mov Disord. 2024 Jan 17. doi:10.1002/mds.29700.
    
4. Groppa S, Gonzalez-Escamilla G, Tinkhauser G, et al. Perspectives of Implementation of Closed-Loop Deep Brain Stimulation: From Neurological to Psychiatric Disorders. Stereotact Funct Neurosurg. 2024;102(1):40-54. doi:10.1159/000535114.
    
5. Kim JJ #, Vitale D #, Véliz Otani D #, Lian MM #, (...) Global Parkinson’s Genetics Program (GP2) [Krack P], et al. Multi-ancestry genome-wide association meta-analysis of Parkinson's disease. Nat Genet. 2024 Jan;56(1):27-36. doi:10.1038/s41588-023-01584-8.
    
6. Magalhães AD, Amstutz D, Petermann K, Debove I, Sousa M, Maradan-Gachet ME, Lachenmayer ML, Waskönig J, Murcia-Carretero S, Diamantaras AA, Tinkhauser G, Nowacki A, Pollo C, Rodriguez-Blazquez C, Martinez-Martin P, Krack P. Subthalamic stimulation has acute psychotropic effects and improves neuropsychiatric fluctuations in Parkinson's disease. MJ Neurol Open. 2024 Jan 6;6(1):e000524. doi:10.1136/bmjno-2023-000524.
    
7. Single M, (...) Krack P, Klöppel S, Müri RM, Mosimann UP, Nef T. A Transferable Lidar-Based Method to Conduct Contactless Assessments of Gait Parameters in Diverse Home-like Environments. Sensors. 2024, 24(4): 1172. doi:10.3390/s24041172.
    
8. Wirth T, Krack P, et al. Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study. J Neurol. 2024 Jan 12. doi:10.1007/s00415-023-12170-7.

ZfPB/SWEZ

1. Ferini-Strambi L, (...) Gnarra O, Krack P, Manconi M, Noain D, Saxena S, Kallweit U, (...) Bassetti C. Role of sleep in neurodegeneration: the consensus report of the 5th Think Tank World Sleep Forum. Neurol Sci. 2024 Feb;45(2):749-767. doi:10.1007/s10072-023-07232-7.

Headache

1. Pohl H, (...) Riederer F, Gantenbein AR, Michels L. Occipital transcranial direct current stimulation in episodic migraine patients: effect on cerebral perfusion. Sci Rep. 2023 Aug 25;13(1):13944. doi:10.1038/s41598-023-39659-5.
    
2. Riederer F, Leis S, Herta J. Pain syndromes in cranial nerves. In: Grisold/ Struhal/ Grisold. The Cranial Nerves in Neurology. Springer, Cham. Springer eBooks. pp. 275–288.
    
3. Schankin C, Diener HC. Zervikogener Kopfschmerz. In: Diener/ Gerloff/ Dieterich /Endres (Hrsg.). Therapie und Verlauf neurologischer Erkrankungen Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer. 8., erweiterte und überarbeitete Auflage 2023. pp. 120-128.
    
4. Wijeratne T, Wijeratne C, Korajkic N, Bird S, Sales C, Riederer F. Secondary headaches - red and green flags and their significance for diagnostics. eNeurologicalSci. 2023 Jun 30:32:100473. doi:10.1016/j.ensci.2023.100473.

Neuroimmunology

1. Naia L, (...) Lim Falk V, et al. Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models. Mol Psychiatry. 2023 Nov 1. doi:10.1038/s41380-023-02289-4.

Neuropsychology

1. Balloff C, (...) Penner IK, Groiss SJ. The importance of pyramidal tract integrity for cortical plasticity and related functionality in patients with multiple sclerosis. Front Neurol. 2023 Nov 24:14:1266225. doi:10.3389/fneur.2023.1266225.

Schwindel

1. Kerkeni H, Beise U, Rosemann A, Erni S. Guideline Schwindel. 2023 Verein mediX Schweiz. Schwindel (medix.ch)
    
2. Zwergal A, Mantokoudis G, Heg D, Kerkeni H, Diener S, Kalla R, Korda A, Candreia C, Welge-Lüssen A, Tarnutzer AA. What is the current status of care by neuro-otology specialists in Switzerland- A national survey. Frontiers in Neurology. 14; 2023. doi:10.3389/fneur.2023.1322330.

SWEZ/Stroke

1. Filchenko I, Mürner N, Dekkers MPJ, Baillieul S, Duss SB, Brill AK, Horvath T, Heldner MR, Rexhaj E, Bernasconi C, Bassetti CLA, Schmidt MH. Blood pressure variability, nocturnal heart rate variability and endothelial function predict recurrent cerebro-cardiovascular events following ischemic stroke. Front Cardiovasc Med. 2023 Nov 16:10:1288109. doi:10.3389/fcvm.2023.1288109.

Stroke

1. Al-Shahi Salman R, (...) Collaboration of Controlled Randomised Trials of Long-Term Oral Antithrombotic Agents After Spontaneous Intracranial Haemorrhage (COCROACH) [Seiffge D]. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Lancet Neurol. 2023 Dec;22(12):1140-1149. doi:10.1016/S1474-4422(23)00315-0.
    
2. Beyeler M, Rea E, Weber L, Belachew NF, Barvulsky Aleman E, Kielkopf M, Kurmann CC, Grunder L, Piechowiak EII, Meinel TR, Heldner MR, Seiffge D, Pilgram-Pastor S, Dobrocky T, Pabst T, Berger MD, Jung S, Arnold M, Gralla J, Fischer U, Kaesmacher J #, Mujanovic A. # Susceptibility vessel sign, a predictor of long-term outcome in patients with stroke treated with mechanical thrombectomy. J Neurointerv Surg. 2023 Nov 2:jnis-2023-020793. doi:10.1136/jnis-2023-020793.
    
3. Galea R, Seiffge D, Räber L. Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation. J Clin Med. 2023 Sep 5;12(18):5784. doi:10.3390/jcm12185784.
    
4. Nash PS, (...) Seiffge D, et al. Associations of renal function with cerebral small vessel disease and functional outcome in acute intracerebral haemorrhage: A hospital-based prospective cohort study. J Neurol Sci. 2023 Sep 15:452:120743. doi:10.1016/j.jns.2023.120743.
    
5. Pascarella R, Antonenko K, (...) Heldner MR, et al. European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS). Eur Stroke J. 2023 Dec;8(4):842-879. doi:10.1177/23969873231190431.
    
6. Soleman J, Macdonald RL, Seiffge D, Greuter L. Antithrombotic medication in neurosurgery: management and controversies of a growing clinical dilemma. Neurosurg Focus. 2023 Oct;55(4):E1. doi:10.3171/2023.8.FOCUS23535.
    
7. Zedde M, (...) Seiffge DJ, et al. The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue. Biomedicines. 2023 Sep 28;11(10):2663. doi:10.3390/biomedicines11102663.

SWEZ

1. Wenz ES, Schinkelshoek MS, Kallweit U, Fronczek R, Rezaei R, Khatami R, Lammers GJ, Bassetti CLA. Narcolepsy type 1 and Sydenham chorea - Report of 3 cases and review of the literature. Sleep Med. 2023 Dec:112:234-238. doi:10.1016/j.sleep.2023.10.028.
    
2. Xiao F, Caciagli L, et al. Identification of different MRI atrophy progression trajectories in epilepsy by subtype and stage inference. Brain. 2023 Nov 2;146(11):4702-4716. doi:10.1093/brain/awad284.

ZEN

1. Adamantidis AR, de Lecea L. Sleep and the hypothalamus. Science. 2023 Oct 27;382(6669):405-412. doi:10.1126/science.adh8285.

ZfPB

1. Béreau M, (...) Krack P, Anheim M. Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson’s disease. Sci Rep. 2023 Dec 1;13(1):21234. doi:10.1038/s41598-023-48188-0.
    
2. Šubert M, (...) Rusz J. Spoken language alterations can predict phenoconversion in isolated REM sleep behavior disorder: a multicentric study. Ann Neurol. 2023 Nov 23. doi:10.1002/ana.26835.

Headache

1. Riederer F, Beiersdorf J, Scutelnic A, Schankin CJ. Migraine Aura-Catch Me If You Can with EEG and MRI-A Narrative Review. Diagnostics (Basel). 2023 Sep 2;13(17):2844. doi:10.3390/diagnostics13172844.

Neuroimmunology

1. Bagnoud M, Remlinger J, Joly S, Massy M, Salmen S, Chan A, Karathanassis D, Evangelopoulos ME, Hoepner R. Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis. CNS Neurosci Ther. 2023 Oct 10. doi:10.1111/cns.14484.
    
2. Bagnoud M, Remlinger J, Massy M, Lodygin D, Salmen A, Chan A, Lühder F, Hoepner R. In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling. Cells. 2023 Sep 15;12(18):2291. doi:10.3390/cells12182291.
    
3. Zettl UK, (...) Chan A, Hecker M. Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation. Expert Rev Clin Immunol. 2023 Jul-Dec;19(11):1343-1359. doi:10.1080/1744666X.2023.2248391.

Neuropsychology

1. Gold SM, (...) Penner IK, et al. Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial. Lancet Digit Health. 2023 Oct;5(10):e668-e678.
   doi:10.1016/S2589-7500(23)00109-7.
    
2. Renner A, Bätge SJ, Filser M, Lau S, Pöttgen J, Penner IK. Non-pharmacological randomized intervention trial for the management of neuropsychological symptoms in outpatients with progressive multiple sclerosis. Appl Neuropsychol Adult. 2023 Aug 31:1-13. doi:10.1080/23279095.2023.2233648.

Psychosomatic Medicine

1. Vanini G, Bühler J, Samantha Weber S, Steinauer M, Aybek S. Healthcare employment as a risk factor for functional neurological disorder: A case–control study. Eur J Neurol. 2023 Sep 11. doi:10.1111/ene.16056.

Schwindel

1. Mantokoudis G, Zwergal A, Heg D, Kerkeni H, Diener S, Kalla R, et al. Needs and supporting tools for primary care physicians to improve care of patients with vertigo and dizziness: a national survey. Front Neurol. 2023 Aug 29:14:1254105. doi:10.3389/fneur.2023.1254105.
    
2. Nikles F, Kerkeni H, Zamaro E, Korda A, Wagner F, Sauter TC, Kalla R, et al. Do monosymptomatic stroke patients with dizziness present a vestibular syndrome without nystagmus? An underestimated entity. Eur J Neurol. 2023 Sep 22. doi:10.1111/ene.16066.
    
3. Zwergal A, Mantokoudis G, Heg D, Kerkeni H, Diener S, Kalla R, et al. What is the current status of primary care in the diagnosis and treatment of patients with vertigo and dizziness in Switzerland? A national survey. Front Neurol. 2023 Sep 7:14:1254080. doi:10.3389/fneur.2023.1254080. 

Silimon/Bassetti

1. Silimon N, Wiest R, Bassetti CLA. Four New Cases of Progressive Ataxia and Palatal Tremor (PAPT) and a Literature Review. Clinical and Translational Neuroscience. 2023; 7(4):32. doi:10.3390/ctn7040032.

Stroke

1. Beyeler M, Castigliego P, Baumann J, Ziegler V, Kielkopf M, Mueller M, Bauer-Gambelli SA, Mujanovic A, Meinel TR, Horvath T, Fischer U, Kaesmacher J, Heldner MR, Seiffge D, Arnold M, Pabst T, Berger MD, Navi BB, Jung S #, Bücke P #. Transient ischemic attacks in patients with active and occult cancer. Front Neurol. 2023 Sep 28:14:1268131. doi:10.3389/fneur.2023.1268131.
    
2. Beyeler M, Pohle F, Weber L, Mueller M, Kurmann CC, Mujanovic A, Clénin L, Piechowiak EI, Meinel TR, Bücke P, Jung S, Seiffge D, Pilgram-Pastor SM, Dobrocky T, Arnold M, Gralla J, Fischer U, Mordasini P, Kaesmacher J. Long-Term Effect of Mechanical Thrombectomy in Stroke Patients According to Advanced Imaging Characteristics. Clin Neuroradiol. 2023 Aug 29. doi:10.1007/s00062-023-01337-4.
    
3. Goeldlin MB, Vynckier J, Mueller M, Drop B, Maamari B, Vonlanthen N, Siepen BM, Hakim A, Kaesmacher J, Jesse CM, Mueller MD, Meinel TR, Beyeler M, Clénin L, Gralla J, Z'Graggen W, Bervini D, Arnold M, Fischer U, Seiffge DJ. Small vessel disease burden and risk of recurrent cerebrovascular events in patients with lacunar stroke and intracerebral haemorrhage attributable to deep perforator arteriolopathy. Eur Stroke J. 2023 Aug 26:23969873231193237. doi:10.1177/23969873231193237.
    
4. Majoie CB, (...) Meinel T, (...) Fischer U; IRIS collaborators. Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials. Lancet. 2023 Sep 16;402(10406):965-974. doi:10.1016/S0140-6736(23)01142-X.
    
5. Schuler FAF, Ribó M, Dequatre-Ponchelle N, Rémi J, Dobrocky T, Goeldlin MB, Gralla J, Kaesmacher J, Meinel TR, Mordasini P, Seiffge DJ, Fischer U, Arnold M, Kägi G, Jung S. Geographical Requirements for the Applicability of the Results of the RACECAT Study to Other Stroke Networks. J Am Heart Assoc. 2023 Oct 17;12(20):e029965. doi:10.1161/JAHA.123.029965.
    
6. Sperber C, Gallucci L, Mirman D, Arnold M, Umarova RM. Stroke lesion size - Still a useful biomarker for stroke severity and outcome in times of high-dimensional models. Neuroimage Clin. 2023 Sep 18:40:103511. doi:10.1016/j.nicl.2023.103511.
    
7. Weller J, (...) Scutelnic A, Heldner MR, (...) Arnold M, et al. Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Eur Stroke J. 2023 Sep 28:23969873231202363. doi:10.1177/23969873231202363.

SWEZ

1. Andrzejak RG, Espinoso A, García-Portugués E, Pewsey A, Epifanio J, Leguia MG, Schindler K. High expectations on phase locking: Better quantifying the concentration of circular data. Chaos. 2023 Sep 1;33(9):091106. doi:10.1063/5.0166468.
    
2. Caciagli L, et al. Cognitive phenotype of juvenile absence epilepsy: An investigation of patients and unaffected siblings. Epilepsia. 2023 Oct;64(10):2792-2805. doi:10.1111/epi.17719.
    
3. Krestel H, Schreier DR, Sakiri E, von Allmen A, Abukhadra Y, Nirkko A, (...) Mathis J, Blumenfeld H. Predictive Power of Interictal Epileptiform Discharges in Fitness-to-Drive Evaluation. Neurology. 2023 Aug 29;101(9):e866-e878. doi:10.1212/WNL.0000000000207531.

ZfPB

1. Illner V, (...) Rusz J. Automated Vowel Articulation Analysis in Connected Speech Among Progressive Neurological Diseases, Dysarthria Types, and Dysarthria Severities. J Speech Lang Hear Res. 2023 Aug 3;66(8):2600-2621. doi:10.1044/2023_JSLHR-22-00526.
    
2. Kouba T, (...) Rusz J. Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages. Eur J Neurol. 2023 May;30(5):1262-1271. doi:10.1111/ene.15726.
    
3. Rusz J, et al. Speech and gait abnormalities in motor subtypes of de-novo Parkinson's disease. CNS Neurosci Ther. 2023 Aug;29(8):2101-2110. doi:10.1111/cns.14158.
    
4. Šubert M, (...) Rusz J. Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis. Ther Adv Neurol Disord. 2023 Jun 25:16:17562864231180719. doi:10.1177/17562864231180719.

Connecting Women in Neurosciences

1. Goeldlin MB, Wenz ES, Kottler C, Fischer U, Bassetti CLA, Aybek S, Heldner MR. Connecting Women in Neurosciences: A networking project to sustain mutual empowerment in young, female clinical neuroscientists. Front Neurol. 2023 Jun 26;14:1130090. doi:10.3389/fneur.2023.1130090.

Headache

1. Scutelnic A, Drangova D, Klein A, Slavova N, Beyeler M, Lippert J, Silimon N, Meinel TR, Arnold M, Fischer U, Riederer F, Mattle HP, Jung S, Schankin CJ. Changes of migraine aura with advancing age of patients. J Headache Pain. 2023 Aug 1;24(1):100. doi:10.1186/s10194-023-01642-w.

Neuroimmunology

1. Lebrun-Frénay C, (...) Hoepner R, et al. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA Neurol. 2023 Aug 21;e232815. doi:10.1001/jamaneurol.2023.2815.
    
2. Pernet V, Joly S, Spiegel S, Meli I, Idriss S, Maigler F, Mdzomba JB, (...) Chan A. Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNS. Cell Death Discov. 2023 Aug 9;9(1):290. doi:10.1038/s41420-023-01588-7.
    
3. Remlinger J, Bagnoud M, Meli I, Massy M, Hoepner R, Linington C, Chan A, Bennett JL, Enzmann V, Salmen A. Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations. Neurol Neuroimmunol Neuroinflamm. 2023 Jul 10;10(5):e200141. doi:10.1212/NXI.0000000000200141.
    
4. Todea AR, (...) Chan A, Salmen A, et al. A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. J Magn Reson Imaging. 2023 Sep;58(3):864-876. doi:10.1002/jmri.28618.
    
5. Salmen A, Marti S, Hoepner AGF, Chan A, Hoepner R. The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis. Front Pharmacol. 2023 Jun 15;14:1186404. doi:10.3389/fphar.2023.1186404.

Neuromuscular Center

1. Abbuehl LS, Hofmann E, Hakim A, Dietmann A. Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? A narrative review. Front Neurol. 2023 Jun 26;14:1130090. doi:10.3389/fneur.2023.1130090.
    
2. Ripellino P, Agustina Maria Lascano AM, Olivier Scheidegger O, (...) Dietmann A, et al. Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study. Eur J Neurol. 2023 Aug 7. doi:10.1111/ene.16030.

Neurorehabilitation

1. Sperber C, Hakim A, Gallucci L, Seiffge D, Rezny-Kasprzak B, Jäger E, Meinel T, Wiest R, Fischer U, Arnold M, Umarova R. A typology of cerebral small vessel disease based on imaging markers. J Neurol. 2023 Jun 27. doi:10.1007/s00415-023-11831-x.
    
2. Lippert J, Guggisberg AG. Diagnostic and Therapeutic Approaches in Neurorehabilitation after Traumatic Brain Injury and Disorders of Consciousness. Clinical and Translational Neuroscience. 2023; 7(3):21. doi.org/10.3390/ctn7030021.

Psychosomatic Medicine

1. Diamantaras AA, Blondiaux E, Schumacher R, Müri RM, Blanke O, Heydrich L. The neuropsychology and neuroanatomy of reduplicative paramnesia. Cortex. 2023 Jul 10;167:12-24. doi:10.1016/j.cortex.2023.06.006.

Stroke

1. Backus B, (...) Seiffge D, Gibler B. Management of major bleeding for anticoagulated patients in the Emergency Department: an European experts consensus statement. Eur J Emerg Med. 2023 Jul 7. doi:10.1097/MEJ.0000000000001049.
    
2. Costamagna G, Navi BB, Beyeler M, et al. Ischemic Stroke in Cancer: Mechanisms, Biomarkers, and Implications for Treatment. Semin Thromb Hemost. 2023 Jul 28. doi:10.1055/s-0043-1771270.
    
3. Fandler-Höfler S, (...) Seiffge D, et al. Association of the Presence and Pattern of MRI Markers of Cerebral Small Vessel Disease With Recurrent Intracerebral Hemorrhage. Neurology. 2023 Aug 22;101(8):e794-e804. doi:10.1212/WNL.0000000000207510.
    
4. Moutzouri E, (...) Seiffge D, (...) Fischer U, et al. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study. Int J Stroke. 2023 Jun 17;17474930231181010. doi:10.1177/17474930231181010.
    
5. Palazzo P, (...) Antonenko K, (...) Heldner MR; MINOR STROKE Collaborators. Relevance of National Institutes of Health Stroke Scale subitems for best revascularization therapy in minor stroke patients with large vessel occlusion: An observational multicentric study. Eur J Neurol. 2023 Jul 30. doi:10.1111/ene.16009.
    
6. Polymeris AA, Karwacki GM, Siepen BM, (...) Fischer U, Z'Graggen WJ, Engelter ST #, Seiffge DJ #, Peters N #, Lyrer PA #; TICH-NOAC Investigators. Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial. Stroke. 2023 Jul 19. doi:10.1161/STROKEAHA.123.042866.
    
7. Santschi A,* Schreier DR,* Hertig-Godeschalk A, Knobel SEJ, Herrmann US, (...)Mathis J. Eyelid Closure Behavior of Patients with Idiopathic and Nonorganic Hypersomnia, Narcolepsy-Cataplexy, and Healthy Controls in the Maintenance of Wakefulness Test. Nat Sci Sleep. 2023;15:677-690. doi:10.2147/NSS.S408318.
    
8. Scutelnic A, (...) Arnold M, Heldner MR. Cerebral Venous Sinus Thrombosis with Thrombocytopenia Syndrome Study Group. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19. Eur Stroke J. 2023 Jul 11;23969873231185213. doi:10.1177/23969873231185213.
    
9. Zietz A, (...) Seiffge DJ, (...) Fischer U, et al. The impact of competing stroke etiologies in patients with atrial fibrillation. Eur Stroke J. 2023 Jul 4;23969873231185220. doi:10.1177/23969873231185220.

SWEZ

1. Carzaniga FS, Hersche M, Schindler K, Rahimi A. VSA-based Positional Encoding Can Replace Recurrent Networks in Emergent Symbol Binding. NeSy 2023: 17th International Workshop on Neural-Symbolic Learning and Reasoning. Link.
    
2. Rebsamen M, Zongxin Jin B, Klail T, De Beukelaer S, Barth R, Rezny-Kasprzak B, Ahmadli U, Vulliemoz S, Seeck M, Schindler K, Wiest R, Radojewski P, Rummel C. Clinical Evaluation of a Quantitative Imaging Biomarker Supporting Radiological Assessment of Hippocampal Sclerosis. Clin Neuroradiol. 2023 Jun 26. doi:10.1007/s00062-023-01308-9.

ZEN/SWEZ/NeuroTec

1. Aellen FM, Van der Meer J, Dietmann A, Schmidt M, Bassetti CLA, Tzovara A. Disentangling the complex landscape of sleep-wake disorders with data-driven phenotyping: A study of the Bernese center. Eur J Neurol. 2023 Aug 2. doi:10.1111/ene.16026.
    
2. Zubler F, Tzovara A. Deep learning for EEG-based prognostication after cardiac arrest: from current research to future clinical applications. Front Neurol. 2023 Jul 24;14:1183810. doi:10.3389/fneur.2023.1183810.

ZfPB

1. Segura-Amil A, Nowacki A, Debove I, Petermann K, Tinkhauser G, Krack P, Pollo C, Nguyen TAK. Programming of subthalamic nucleus deep brain stimulation with hyperdirect pathway and corticospinal tract-guided parameter suggestions. Hum Brain Mapp. 2023 Aug 15;44(12):4439-4451. doi:10.1002/hbm.26390.

Center for Rare Disease

1. Bremova-Ertl T, Schneider S. Current advancements in therapy for Niemann-Pick disease: progress and pitfalls. Expert Opin Pharmacother. 2023 May 21;1-19. doi:10.1080/14656566.2023.2215386.
    
2. Fields T, Bremova TM, et al. N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study. Trials. 2023 May 29;24(1):361. doi:10.1186/s13063-023-07399-6.

Headache

1. Panos LD, Schankin CJ. Migräne im Alltag. Therapie, Hindernisse und neue Erkenntnisse. InFo Neurologie&Psychiatrie 2023; Vol.21, Nr.2: 6 - 16. Link

Neuroimmunology

1. Diem L, Höfle O, Fregolente L, Hoepner R. The Role of Neurorehabilitation in Post-COVID-19 Syndrome. Clinical and Translational Neuroscience 7, no. 2: 13. doi:10.3390/ctn7020013.
    
2. Hammer H, Kamm CP, Salmen A and Hoepner R. Comparable Efficacy of SARS-CoV-2 mRNA Vaccines (BNT162b2 and mRNA-1273) in Fingolimod-Treated Patients with Multiple Sclerosis. Biomed J Sci & Tech Res 50(1)-2023. BJSTR. MS.ID.007885. doi:10.26717/BJSTR.2023.50.007885.
    
3. Nittas V, Zecca C, Kamm CP, Kuhle J, Chan A, von Wyl V. Digital health for chronic disease management: An exploratory method to investigating technology adoption potential. PLoS One. 2023 Apr 13;18(4):e0284477. doi:10.1371/journal.pone.0284477.

Neurorehabilitation

1. Göbel N, Cazzoli D, Gutbrod C, Müri RM, Eberhard-Moscicka AK. An item sorting heuristic to derive equivalent parallel test versions from multivariate items. PLoS One. 2023 Apr 25;18(4):e0284768. doi:10.1371/journal.pone.0284768.
    
2. Rivier C, Preti MG, Nicolo P, Van De Ville D, Guggisberg AG, Pirondini E. Prediction of post-stroke motor recovery benefits from measures of sub-acute widespread network damages. Brain Commun. 2023 Mar 1;5(2):fcad055. doi:10.1093/braincomms/fcad055.
    
3. Sperber C, Gallucci L, Umarova R. Reply: The correlation of behavioural deficits post-stroke: a trivial issue? Brain. 2023 May 24;awad174. doi:10.1093/brain/awad174.

Psychosomatic Medicine

1. Barth R, Gegusch M. [Functional Neurological Disorders - A Common but Often Unrecognized Diagnosis] [Article in German]. Praxis (Bern 1994). 2023 Apr;112(5-6):329-334. doi:10.1024/1661-8157/a003997.

Stroke

1. Bonaventure Ip YM, (...) Seiffge D, Leung TW. Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant. Neurology. 2023 May 24;10.1212/WNL.0000000000207422. doi:10.1212/WNL.0000000000207422.
    
2. Dalla Vecchia LA, Arnold M, Sarikaya H. Stroke mimics und Stroke chameleons. der informierte Arzt_04_2023. doi:10.23785/ARZT.2023.04.001.
    
3. Lindgren E, Krzywicka K, de Winter MA, Sánchez Van Kammen M, Heldner MR, (...) Scutelnic A, (...) Arnold M., et al. A scoring tool to predict mortality and dependency after cerebral venous thrombosis. Eur J Neurol. 2023 May 10. doi:10.1111/ene.15844.
    
4. Salehi Omran S, (..) Heldner MR, et al. Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis. J Stroke. 2023 May;25(2):291-298. doi:10.5853/jos.2023.00213.
    
5. Silimon N, Drop B, Clénin L, Nedeltchev K, (...) Fischer U, Jung S, Arnold M, Meinel T, Seiffge D. Ischaemic stroke despite antiplatelet therapy: Causes and outcomes. European Stroke Journal. 2023;0(0). doi:10.1177/23969873231174942.
    
6. van de Munckhof A, (...) Heldner MR, Arnold M, et al. Cerebral Venous Sinus Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia in Middle-Income Countries. Int J Stroke. 2023 Jun 5;17474930231182901. doi:10.1177/17474930231182901.

SWEZ/ZEN

1. Krone LB, Fehér KD, Rivero T, Omlin X. Brain stimulation techniques as novel treatment options for insomnia: A systematic review. J Sleep Res. 2023 May 18;e13927. doi:10.1111/jsr.13927.
    
2. Wagenhäuser I, (...) Krone LB. The relationship between mental health, sleep quality and the immunogenicity of COVID-19 vaccinations. J Sleep Res. 2023 May 13;e13929. doi:10.1111/jsr.13929.

ZfPB

1. Alva L, Bernasconi E, Torrecillos F, Fischer P, Averna A, (...) Tinkhauser G. Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation. Clin Neurophysiol. 2023 May 16;152:43-56. doi:10.1016/j.clinph.2023.04.013.
    
2. Neumann WJ, Gilron R, Little S, Tinkhauser G. Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation. Mov Disord. 2023 May 6. doi:10.1002/mds.29415.
    
3. Sousa M, Maamari B, Bremova T, Nuoffer JM, Wiest R, Amstutz D, Krack P, Bartholdi D, Tinkhauser G. Late adult-onset Niemann Pick type C (NPC): An “atypical” typical presentation at the age of 62. Parkinsonism & Related Disorders, 2023, 105460. doi:10.1016/j.parkreldis.2023.105460.

Neuroimmunology

1. Betancourt AL, Schwarzwald A, Millonig A, Oberholzer M, Sabater L, Hammer H, Kamber N, Diem L, Chan A, Hoepner R, Salmen A, Friedli C. Anti-kelchlike protein 11 antibody-associated encephalitis: Two case reports and review of the literature. Eur J Neurol. 2023 Feb 23. doi:10.1111/ene.15758.
    
2. Stanikić M, Twomey E, Puhan MA, Kamm CP, Salmen A, et al. Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry. Mult Scler Relat Disord. 2023 Apr 7;74:104707. doi:10.1016/j.msard.2023.104707.

Neuromuscular Disease

1. Dietmann A, Blanquet M, Rösler KM, Scheidegger O. Effects of high resistance muscle training on corticospinal output during motor fatigue assessed by transcranial magnetic stimulation. Front Physiol. 2023 Mar 10;14:1125974. doi:10.3389/fphys.2023.1125974.

Neuropsychology

1. Baetge SJ, Filser M, Renner A, Raithel LM, Lau S, Pöttgen J, Penner IK. Supporting brain health in multiple sclerosis: exploring the potential of neuroeducation combined with practical mindfulness exercises in the management of neuropsychological symptoms. J Neurol. 2023 Feb 25;1-14. doi:10.1007/s00415-023-11616-2.
    
2. Bogaardt H, (...) Penner IK, et al. Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS? Mult Scler Relat Disord. 2023 Mar 21;73:104630. doi:10.1016/j.msard.2023.104630.
    
3. Pokryszko-Dragan A, Penner IK, Comi G. Editorial: Fatigue in multiple sclerosis-A current perspective. Front Neurol. 2023 Feb 7;14:1150717. doi:10.3389/fneur.2023.1150717.

Neurorehabilitation

1. Makowka S, Mory LN, Mouthon M, Mancini C, Guggisberg AG, Nsimire Chabwine J. EEG Beta functional connectivity decrease in the left amygdala correlates with the affective pain in fibromyalgia: A pilot study. PLoS One. 2023 Feb 21;18(2):e0281986. doi:10.1371/journal.pone.0281986.
    
2. Sperber C, Gallucci L, Smaczny S, Umarova R. Bayesian lesion-deficit inference with Bayes factor mapping: Key advantages, limitations, and a toolbox. Neuroimage. 2023 May 1;271:120008. doi:10.1016/j.neuroimage.2023.120008.
    
3. Wessel MJ #, Draaisma LR #, (...) Guggisberg AG, Hummel FC. Multi-focal Stimulation of the Cortico-cerebellar Loop During the Acquisition of a Novel Hand Motor Skill in Chronic Stroke Survivors. Cerebellum. 2023 Feb 18. doi:10.1007/s12311-023-01526-4.

Stroke

1. Benz AP, (...) Seiffge DJ, et al. Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. Eur Heart J. 2023 Apr 11;ehad200. doi:10.1093/eurheartj/ehad200.
    
2. Beyeler M, Grunder L, Göcmen J, Steinauer F, Belachew NF, Kielkopf M, Clénin L, Mueller M, Silimon N, Kurmann C, Meinel T, Bücke P, Seiffge D, Dobrocky T, Piechowiak EI, Pilgram-Pastor S, Mattle HP, Navi BB, Arnold M, Fischer U, Pabst T, Gralla J, Berger MD, Jung S, Kaesmacher J. Absence of susceptibility vessel sign and hyperdense vessel sign in patients with cancer-related stroke. Front Neurol. 2023 Mar 20;14:1148152. doi:10.3389/fneur.2023.1148152.
    
3. Kielkopf MC. Ischämischer Hirninfarkt. Plättchenhemmung und Lipidsenkung nach ischamischem Schlaganfall. Schweizer Zeitschrift für Psychiatrie & Neurologie 01/2023. Link.
    
4. Krzywicka K, Aguiar de Sousa D, (...) Scutelnic A, Heldner MR, (...) Arnold M, et al. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Eur J Neurol. 2023 May;30(5):1335-1345. doi:10.1111/ene.15735.
    
5. Lyrer F, Zietz A, Seiffge DJ, Koga M, Volbers B, et al. Atrial Fibrillation Detected before or after Stroke: Role of Anticoagulation. Ann Neurol. 2023 Mar 28. doi:10.1002/ana.26654.
    
6. Sabben C, Charbonneau F, Delvoye F, Strambo D, Heldner MR, et al. Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study. Stroke. 2023 Apr;54(4):928-937. doi:10.1161/STROKEAHA.122.042283.
    
7. Scutelnic A, Justus L, Branca M, Meinel TR, Beyeler M, Silimon N, Drop BRH, Seiffge DJ, Fischer U, Arnold M, Mattle HP, Schankin CJ, Jung S. Factors associated with migraine aura-like symptoms in acute ischemic stroke. J Neurol. 2023 Apr 4. doi:10.1007/s00415-023-11694-2.
    
8. Schwarzwald A, Fischer U, Seiffge D, Beyeler M, Scutelnic A, Kaesmacher J, Mordasini P, Dobrocky T, Gralla J, Heldner MR, Umarova R, Meinel TR, Arnold M, Jung S, Goeggel Simonetti B. Impact of sex in stroke in the young. PLoS One. 2023 Mar 31;18(3):e0274722. doi:10.1371/journal.pone.0274722.
    
9. Soo Y, Zietz A, Yiu B, Mok VCT, Polymeris AA, Seiffge D. et al. Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation. Ann Neurol. 2023 Mar 17. doi:10.1002/ana.26642.

SWEZ

1. Bou Assi E, Schindler K, et al. From basic sciences and engineering to epileptology: A translational approach. Epilepsia. 2023 Mar 2. doi:10.1111/epi.17566.
    
2. Köstner M, Rebsamen M, Radojewski P, Rummel C, Jin B, Meier R, Ahmadli U, Schindler K, Wiest R. Large-scale transient peri-ictal perfusion magnetic resonance imaging abnormalities detected by quantitative image analysis. Brain Commun. 2023 Feb 24;5(2):fcad047. doi:10.1093/braincomms/fcad047.

SWEZ/NeuroTec/ZEN

1. Cusinato R, Alnes SL, van Maren E, Boccalaro I, Ledergerber D, Antoine Adamantidis A, Imbach LL, Schindler K, Baud MO, Tzovara A. Intrinsic neural timescales in the temporal lobe support an auditory processing hierarchy. J Neurosci. 2023 Apr 11;JN-RM-1941-22. doi:10.1523/JNEUROSCI.1941-22.2023.

SWEZ/NeuroTec/ZfPB/Neuroimmunology

1. Single M, Bruhin LC, Schütz N, Naef AC, Hegi H, Reuse P, Schindler KA, Krack P, Wiest R, Chan A, Nef T #, Gerber SM #. Development of an Open-source and Lightweight Sensor Recording Software System for Conducting Biomedical Research: Technical Report. JMIR Form Res. 2023 Feb 17;7:e43092. doi:10.2196/43092.

ZfPB

1. Averna A, Debove I, Nowacki A, Peterman K, Duchet B, Sousa M, Bernasconi E, Alva L, Lachenmayer ML, Schuepbach M, Pollo C, Krack P, Nguyen TAK, Tinkhauser G. Spectral Topography of the Subthalamic Nucleus to Inform Next-Generation Deep Brain Stimulation. Mov Disord. 2023 Mar 28. doi:10.1002/mds.29381.
    
2. Maradan-Gachet ME, Debove I, Lhommée E, Krack P. Creativity and Parkinson’s Disease. Current Clinical Neurology. Humana, Cham. doi:10.1007/978-3-031-14724-1_3.

Headache

1. Scutelnic A, Bracher J, Kreis LA, Beyeler M, Fischer U, Arnold M, Mattle HP, Jung S, Schankin CJ. Symptoms and patterns of symptom propagation in incipient ischemic stroke and migraine aura. Front Hum Neurosci. 2023 Jan 13;16:1077737. doi:10.3389/fnhum.2022.1077737.
    
2. Scutelnic A, Slavova N, Klein A, Horvath T, de Beukelaer SAL, Arnold M, Jung S, Schankin CJ. Symptomatic visual snow in acute ischemic stroke: A case series. Headache. 2023 Jan;63(1):173-176. doi:10.1111/head.14445.
    
3. Zecca C, (...) Schankin CJ, Gobbi C. Response to erenumab assessed by Headache Impact Test-6 is modulated by genetic factors and arterial hypertension: An explorative cohort study. Eur J Neurol. 2023 Jan 10. doi:10.1111/ene.15678.

Neuroimmunology

1. Friedli C, Salmen A, Hoepner R, Achtnichts L, Bigi S, Derfuss T, Gobbi C, Kamber N, Kamm CP, Kuhle J, Lalive P, Müller S, Papadopoulou A, Pot C, Zecca C, Chan A on behalf of the Scientific Advisory Board of the Swiss Multiple Sclerosis Society and the Swiss Neurological Society. Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022. Clinical and Translational Neuroscience. 2023; 7(1):2. doi:10.3390/ctn7010002.
    
2. Meier S, (...) Salmen A, et al. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurol. 2023 Feb 6. doi:10.1001/jamaneurol.2022.5250.
    
3. Penner IK (Ed.) Fatigue in Multiple Sclerosis. Background, Clinic, Diagnostic, Therapy. Springer. 2023 Jan 2. doi:10.1007/978-3-031-13498-2.
    
4. Todea AR, (...) Chan A, Salmen A, et al. A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. J Magn Reson Imaging. 2023 Jan 28. doi:10.1002/jmri.28618.

Neuromuscular Center

1. Kaufmann EM, Krause S, Geisshuesler L, Scheidegger O, Haeberlin A, Niederhauser T. Feasibility of transesophageal phrenic nerve stimulation. Biomed Eng Online. 2023 Jan 30;22(1):5. doi:10.1186/s12938-023-01071-5.

Neurorehabilitation

1. Smaczny S, Sperber C, et al. Disconnection in a left-hemispheric temporo-parietal network impairs multiplication fact retrieval. Neuroimage. 2023 Mar;268:119840. doi:10.1016/j.neuroimage.2022.119840.

Schwindel- und Ganglabor

1. Kerkeni H, et al. Corrective saccades in acute vestibular neuritis: studying the role of prediction with automated passively induced head impulses. J Neurophysiol. 2023 Feb 1;129(2):445-454. doi:10.1152/jn.00382.2022.
    
2. Nuoffer MG, Lefebvre S, Nadesalingam N, (…) Kerkeni H, Kalla R, Walther S. Psychomotor slowing alters gait velocity, cadence, and stride length and indicates negative symptom severity in psychosis. Schizophrenia (Heidelb). 2022 Dec 30;8(1):116. doi:10.1038/s41537-022-00324-x.

Stroke 

1. Martí-Fàbregas J, (…) Seiffge DJ, (…) Goeldlin M, et al. Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis. Neurology Dec 2022, 10.1212/WNL.0000000000201723.
   doi: 10.1212/WNL.0000000000201723.
    
2. Meinel TR, Wilson D, Gensicke H, et al. Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants. JAMA Neurol. January 03, 2023. doi:10.1001/jamaneurol.2022.4782.
    
3. Scutelnic A, Petroulia V, Schraml L, Jung S, Branca M, Beyeler M, Fischer U, Wiest R, Slavova N, Schankin CJ. The “index vein” as a sign for migraine aura in the emergency setting. Cephalalgia. 2023;43(1). doi:10.1177/03331024221132010.

ZEN/SWEZ

1. Aellen FM, Alnes SL, Loosli F, Rossetti AO, Zubler F, De Lucia M, Tzovara A. Auditory stimulation and deep learning predict awakening from coma after cardiac arrest. Brain. 2023 Feb 13;146(2):778-788. doi:10.1093/brain/awac340.

ZfPB

1. Debove I, Petermann K, Nowacki A, Nguyen TAK, Tinkhauser G, Michelis JP, Muellner J, Amstutz D, Bargiotas P, Fichtner J, Schlaeppi JA, Krack P, Schuepbach M, Pollo C, Lachenmayer ML. Deep Brain Stimulation: When to Test Directional? Mov Disord Clin Pract. doi:10.1002/mdc3.13667.
    
2. Jaradat A, Nowacki A, Montalbetti M, Debove I, Petermann K, Schlaeppi JA, Lachenmayer L, Tinkhauser G, Krack P, Nguyen TAK, Pollo C. Probabilistic Subthalamic Nucleus Stimulation Sweet Spot Integration Into a Commercial Deep Brain Stimulation Programming Software Can Predict Effective Stimulation Parameters. Neuromodulation. 2023 Feb;26(2):348-355. doi:10.1016/j.neurom.2021.10.026.
    
3. Pérennou D, (...) Krack P. Retropulsion with tilted postural vertical causing backward falls in an individual with Parkinson's disease: Improvement by specific rehabilitation. Ann Phys Rehabil Med. 2023 Jan 14;66(4):101728. doi:10.1016/j.rehab.2022.101728.
    
4. van Wegen M, Herder JL, Adelsberger R, Pastore-Wapp M, van Wegen EEH, Bohlhalter S, Nef T, Krack P, Vanbellingen T. An Overview of Wearable Haptic Technologies and Their Performance in Virtual Object Exploration. Sensors (Basel). 2023 Feb 1;23(3):1563. doi:10.3390/s23031563.